Norman, Gary L.

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 365

Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency

Lahner, E., Norman, G. L., Severi, C., Encabo, S., Shums, Z., Vannella, L., Fave, G. D., & Annibale, B. (2009) · The American Journal of Gastroenterology

Helicobacter pylori-related gastroenterology studiesCeliac Disease Research and Management

Cited by 174

PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., et al. (2010) · Journal of Autoimmunity

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 130

Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis

Leung, P. S. C., Rossaro, L., Davis, P. A., Park, O., Tanaka, A., Kikuchi, K., Miyakawa, H., Norman, G. L., Lee, W., & Gershwin, E. M. (2007) · Hepatology

Liver Diseases and ImmunityDrug-Induced Hepatotoxicity and Protection

Cited by 121

Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

Murthy, V., Willis, R., Romay‐Penabad, Z., Ruiz‐Limón, P., Martínez‐Martínez, L. A., Jatwani, S., Jajoria, P., Seif, A., Alarcón, G. S., Papalardo, E., et al. (2013) · Arthritis & Rheumatism

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 112

Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Norman, G. L., Yang, C., Ostendorff, H. P., Shums, Z., Lim, M. J., Wang, J., Awad, A., Hirschfield, G. M., Milkiewicz, P., Bloch, D. B., et al. (2015) · Liver International

Liver Diseases and ImmunityAutoimmune Bullous Skin Diseases

Cited by 87

Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG

Pinto-Sanchez, M. I., Nardelli, A., Borojevic, R., De Palma, G., Calo, N. C., McCarville, J., Caminero, A., Basra, D., Mordhorst, A., Ignatova, E., et al. (2021) · Clinical Gastroenterology and Hepatology

Gastrointestinal motility and disordersCeliac Disease Research and Management

Cited by 57

Assessment of health related quality of life in polish patients with primary biliary cirrhosis

Raszeja-Wyszomirska, J., Wunsch, E., Krawczyk, M., Rigopoulou, E. I., Kostrzewa, K., Norman, G. L., Bogdanos, D. P., & Milkiewicz, P. (2016) · Clinics and Research in Hepatology and Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 47

Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Wunsch, E., Norman, G. L., Milkiewicz, M., Krawczyk, M., Bentow, C., Shums, Z., Mahler, M., Lopens, S., Reinhold, D., Franke, A., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 43

THU-095 Novel machine learning algorithm for risk prediction of cholangiocarcinoma in primary sclerosing cholangitis

Wunsch, E., Horecki, M., Milkiewicz, M., Kruk, B., Fischer, K., Winikajtis-Burzyńska, A., Norman, G., Roggenbuck, D., & Milkiewicz, P. (2024) · Journal of Hepatology

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 1